tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
2196
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports
Want to see HK:2196 full AI Analyst Report?

Shanghai Fosun Pharmaceutical (Group) Co (2196) Revenue

5 Followers
StatisticsMarket CapRevenue

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 10.07B in the quarter ending Mar 31, 2026, with -53.59%. This bring the company's revenue in the last twelve months to 41.87B, Decreased 1.58%. In the fiscal year ending Dec 31, 2025, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 40.42B with -1.57% growth.
Revenue (ttm)
41.87B
Revenue Growth
1.52%
P/S Ratio
1.76
Revenue/Employee
HK$996,728
Employees
40,557
Market Cap
HK$70.95B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
40.42B-642.89M-1.57%
Dec 31, 2024
41.07B-332.34M-0.80%
Dec 31, 2023
41.40B-2.55B-5.81%
Dec 31, 2022
43.95B4.95B+12.68%
Dec 31, 2021
39.01B8.70B+28.70%
Dec 31, 2020
30.31B1.72B+6.02%
Dec 31, 2019
28.59B3.67B+14.72%
Dec 31, 2018
24.92B6.38B+34.45%
Dec 31, 2017
18.53B――